ReoPro GP IIb/IIIa inhibitor data

Researchers at Cleveland Clinic Foundation (Cleveland, Ohio) and colleagues published results of the EPILOG trial of the anti-platelet antibody in The New England Journal of Medicine. Positive data

Read the full 287 word article

How to gain access

Continue reading with a
two-week free trial.